Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4879
Gene Symbol: NPPB
NPPB
0.560 GeneticVariation group BEFREE Plasma NTproANP, NTproBNP and NTproCNP and their bioactive counterparts were measured in a random sample of 348 community dwellers aged 49-51 yr without heart disease and associations sought with established vascular risk factors, echocardiographic indices and a genetic variant previously linked with BNP. 31431677 2019
Entrez Id: 4879
Gene Symbol: NPPB
NPPB
0.560 GeneticVariation group BEFREE Plasma samples for BNP measurement were repeated in 29 patients (63 ± 11 years) who were alive at 5 years after radiotherapy, free of heart disease and available to provide new blood sample. 30431375 2019
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.380 GeneticVariation group BEFREE Elevation of baseline C-reactive protein (CRP) is associated with increased risk of cardiac disease. 11857055 2002
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.380 GeneticVariation group BEFREE Genetic predisposition to high baseline CRP might account for a high risk of heart diseases. 22828776 2012
Entrez Id: 183
Gene Symbol: AGT
AGT
0.370 GeneticVariation group BEFREE The ThrThr genotype of the angiotensinogen (AGT) Met235Thr polymorphism has been associated with elevated AGT levels, hypertension, increased heart disease risk, and improved blood pressure (BP) response to angiotensin-converting enzyme (ACE) inhibitors. 14643574 2003
Entrez Id: 183
Gene Symbol: AGT
AGT
0.370 GeneticVariation group BEFREE Angiotensin-(1-7) [Ang-(1-7)] exhibits cardiovascular effects opposite those of angiotensin II (Ang II), thus providing protection against heart disease. 28096047 2017
Entrez Id: 5444
Gene Symbol: PON1
PON1
0.330 GeneticVariation group BEFREE We sought to investigate the association of the PON1 Q192R polymorphism with stroke and heart disease. 16472799 2006
Entrez Id: 5444
Gene Symbol: PON1
PON1
0.330 GeneticVariation group BEFREE In order to obtain address this issue we performed a meta-analysis to assess the association between the L55M and Q192R polymorphisms of PON1 gene and heart diseases risk. 27858903 2016
Entrez Id: 126393
Gene Symbol: HSPB6
HSPB6
0.320 GeneticVariation group BEFREE We identified a C59T substitution in the human Hsp20 gene in one patient and three individuals without heart disease. 18790732 2008
Entrez Id: 57104
Gene Symbol: PNPLA2
PNPLA2
0.310 GeneticVariation group BEFREE A novel type of autosomal recessive lipid myopathy due to PNPLA2 mutations was recently described with associated cardiac disease, myopathy and frequent infections, but without ichthyosis. 23232698 2013
Entrez Id: 1535
Gene Symbol: CYBA
CYBA
0.310 GeneticVariation group BEFREE Finally, a large number of genetic variations of CYBA have been reported, among them the C242T polymorphism, which has been extensively studied in association with coronary artery and heart diseases, but conflicting results continue to be reported. 27048830 2016
Entrez Id: 1906
Gene Symbol: EDN1
EDN1
0.240 GeneticVariation group LHGDN The aim of this pilot study was to investigate the frequency distribution of the common polymorphism of the ET-1 gene and its possible relation with hemodynamic consequences of malignant ventricular arrhythmias in patients with structural heart disease. 15838369 2004
Entrez Id: 1906
Gene Symbol: EDN1
EDN1
0.240 GeneticVariation group BEFREE The aim of this pilot study was to investigate the frequency distribution of a common polymorphism of the endothelin (ET-1) gene and its possible relation to the hemodynamic consequences of malignant ventricular arrhythmia in patients with structural heart disease. 12011762 2002
Entrez Id: 1906
Gene Symbol: EDN1
EDN1
0.240 GeneticVariation group BEFREE The aim of this pilot study was to investigate the frequency distribution of the common polymorphism of the ET-1 gene and its possible relation with hemodynamic consequences of malignant ventricular arrhythmias in patients with structural heart disease. 15838369 2004
Entrez Id: 7057
Gene Symbol: THBS1
THBS1
0.210 GeneticVariation group BEFREE A study focusing on candidate genes associated with premature cardiovascular disease discovered that missense variations in the thrombospondin 1 and 4 genes were associated with premature coronary artery disease, while a mutation in the non-coding region of a thrombospondin 2 gene imparts protection from developing heart disease. 12537090 2003
Entrez Id: 5781
Gene Symbol: PTPN11
PTPN11
0.120 GeneticVariation group LHGDN PTPN11 mutations play a minor role in isolated congenital heart disease. 15940693 2005
Entrez Id: 4000
Gene Symbol: LMNA
LMNA
0.100 GeneticVariation group BEFREE Particularly, if neurogenic atrophy is combined with a cardiac disease in a family, this should prompt LMNA mutation analysis. 17136397 2007
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE One variant of apoE (E4) is associated with increased risk for heart disease, stroke and Alzheimer's disease (AD). 12067591 2002
Entrez Id: 7273
Gene Symbol: TTN
TTN
0.100 GeneticVariation group BEFREE The detection rate of rare variants in TTN was not significantly different to that found in the group of patients without structural heart disease. 28771489 2017
Entrez Id: 4000
Gene Symbol: LMNA
LMNA
0.100 GeneticVariation group BEFREE Mutations in the lamin A/C gene (LMNA) may cause familial dilated cardiomyopathy (dilated cardiomyopathy) characterized by early onset atrio-ventricular block (A-V block) before the manifestation of dilated cardiomyopathy and high risk of sudden death due to ventricular arrhythmia, which is very similar to the phenotype of gap junction related heart disease. 20497714 2010
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.100 GeneticVariation group BEFREE An insertion-deletion polymorphism in ACE has recently been linked to heart disease, cerebrovascular disease, and AD. 10681079 2000
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE Cox proportional hazards regression models were constructed to estimate the risk for dementia in terms of relative risks (RRs) for stroke and the APOE epsilon4 allele, with adjustment for age, sex, education, systolic blood pressure, antihypertensive medication use, and heart disease. 10625715 2000
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation group BEFREE Risk factors for MCI at the time of the MRI were identified using logistic regression, controlling for age, race, educational level, baseline Modified Mini-Mental State Examination and Digit Symbol Test scores, measurements of depression, MRI findings (atrophy, ventricular volume, white matter lesions, and infarcts), the presence of the apolipoprotein E (APOE) epsilon4 allele, hypertension, diabetes mellitus, and heart disease. 14568809 2003
Entrez Id: 6262
Gene Symbol: RYR2
RYR2
0.100 GeneticVariation group BEFREE The absence of structural cardiac disease in physical activity-induced sudden death and the finding of three novel RyR2 mutations suggest that mutation screening in such cases should include RyR2. 16436635 2006
Entrez Id: 6262
Gene Symbol: RYR2
RYR2
0.100 GeneticVariation group BEFREE In conclusion, heart failure and exercise-induced sudden cardiac death have been linked to defects in RyR2-calstabin2 regulation, and this may represent a novel target for the prevention and treatment of these forms of heart disease. 15201156 2004